AR009651A1 - Composicion solubilizante/estabilizante anhidra, emulsionable o microemulsionable en agua, para la solubilizacion de los derivados hidrofobosde n-sulfonil indolina, composicion farmaceutica microemulsionable o emulsionable en medio acuoso, y capsulas farmaceuticas, particularmente blandas - Google Patents

Composicion solubilizante/estabilizante anhidra, emulsionable o microemulsionable en agua, para la solubilizacion de los derivados hidrofobosde n-sulfonil indolina, composicion farmaceutica microemulsionable o emulsionable en medio acuoso, y capsulas farmaceuticas, particularmente blandas

Info

Publication number
AR009651A1
AR009651A1 ARP970105696A ARP970105696A AR009651A1 AR 009651 A1 AR009651 A1 AR 009651A1 AR P970105696 A ARP970105696 A AR P970105696A AR P970105696 A ARP970105696 A AR P970105696A AR 009651 A1 AR009651 A1 AR 009651A1
Authority
AR
Argentina
Prior art keywords
composition
solubilizing
indoline
stabilizing
pharmaceutical composition
Prior art date
Application number
ARP970105696A
Other languages
English (en)
Spanish (es)
Original Assignee
Kieger Stephane
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kieger Stephane filed Critical Kieger Stephane
Publication of AR009651A1 publication Critical patent/AR009651A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
ARP970105696A 1996-12-05 1997-12-04 Composicion solubilizante/estabilizante anhidra, emulsionable o microemulsionable en agua, para la solubilizacion de los derivados hidrofobosde n-sulfonil indolina, composicion farmaceutica microemulsionable o emulsionable en medio acuoso, y capsulas farmaceuticas, particularmente blandas AR009651A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9614957A FR2756736B1 (fr) 1996-12-05 1996-12-05 Compositions pharmaceutiques contenant des derives de n-sulfonyl indoline

Publications (1)

Publication Number Publication Date
AR009651A1 true AR009651A1 (es) 2000-04-26

Family

ID=9498376

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP970105696A AR009651A1 (es) 1996-12-05 1997-12-04 Composicion solubilizante/estabilizante anhidra, emulsionable o microemulsionable en agua, para la solubilizacion de los derivados hidrofobosde n-sulfonil indolina, composicion farmaceutica microemulsionable o emulsionable en medio acuoso, y capsulas farmaceuticas, particularmente blandas

Country Status (25)

Country Link
EP (1) EP0941090A1 (is)
JP (1) JP2000507618A (is)
KR (1) KR20000069308A (is)
CN (1) CN1239887A (is)
AR (1) AR009651A1 (is)
AU (1) AU716575B2 (is)
BR (1) BR9712406A (is)
CA (1) CA2273990A1 (is)
CO (1) CO4910129A1 (is)
DZ (1) DZ2362A1 (is)
EE (1) EE9900206A (is)
FR (1) FR2756736B1 (is)
HU (1) HUP0001386A3 (is)
ID (1) ID23373A (is)
IL (1) IL129936A0 (is)
IS (1) IS5062A (is)
MY (1) MY132819A (is)
NO (1) NO992724D0 (is)
NZ (1) NZ335750A (is)
RU (1) RU2174394C2 (is)
SK (1) SK75599A3 (is)
TR (1) TR199901702T2 (is)
WO (1) WO1998024430A1 (is)
YU (1) YU23099A (is)
ZA (1) ZA9710919B (is)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2786486B3 (fr) * 1998-11-16 2000-12-08 Sanofi Sa Procede de preparation du (2s)-1-[(2r,3s)-5-chloro-3-(2- chlorophenyl)-1-(3,4-dimethoxy benzenesulfonyl)-3-hydroxy- 2,3-dihydro-1h-indole-2-carbonyl]pyrrolidine-2-carboxamide, de ses solvats et/ou hydrates
DE19913692A1 (de) * 1999-03-25 2000-09-28 Basf Ag Mechanisch stabile pharmazeutische Darreichungsformen, enthaltend flüssige oder halbfeste oberflächenaktive Substanzen
US6437006B1 (en) 1999-09-27 2002-08-20 American Cyanamid Company Pharmaceutical carrier formulation
JP5767429B2 (ja) 1999-11-12 2015-08-19 アッヴィ・インコーポレイテッド 固体分散剤中の結晶化阻害剤
FR2805992A1 (fr) * 2000-03-08 2001-09-14 Sanofi Synthelabo Compositions pharmaceutiques orales contenant des derives de n-sulfonylindoline
DE10026698A1 (de) 2000-05-30 2001-12-06 Basf Ag Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung
ITMI20011338A1 (it) 2001-06-26 2002-12-26 Farmatron Ltd Composizioni farmaceutiche orali a rilascio immediato del principio attivo
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
UA119324C2 (uk) * 2013-04-02 2019-06-10 Теміс Медікер Лімітед Композиції фармацевтично активних речовин, що містять моноетиловий ефір діетиленгліколю або інші алкільні похідні
KR102139339B1 (ko) * 2013-06-24 2020-07-29 주식회사 엘지생활건강 인돌 화합물을 포함하는 용해도가 개선된 화장료 조성물
KR102139338B1 (ko) * 2013-06-24 2020-07-29 주식회사 엘지생활건강 인돌 화합물을 포함하는 용해도가 개선된 화장료 조성물

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3237814A1 (de) * 1982-10-12 1984-04-12 Warner-Lambert Co., 07950 Morris Plains, N.J. Wasserfreie emulsionen und verwendung derselben
FR2679903B1 (fr) * 1991-08-02 1993-12-03 Elf Sanofi Derives de la n-sulfonyl indoline portant une fonction amidique, leur preparation, les compositions pharmaceutiques en contenant.

Also Published As

Publication number Publication date
BR9712406A (pt) 1999-08-31
WO1998024430A1 (fr) 1998-06-11
EE9900206A (et) 1999-12-15
FR2756736B1 (fr) 1999-03-05
YU23099A (en) 1999-11-22
SK75599A3 (en) 2000-08-14
TR199901702T2 (en) 1999-09-21
NO992724L (no) 1999-06-04
RU2174394C2 (ru) 2001-10-10
NO992724D0 (no) 1999-06-04
HUP0001386A2 (hu) 2001-04-28
CO4910129A1 (es) 2000-04-24
EP0941090A1 (fr) 1999-09-15
AU5326298A (en) 1998-06-29
ZA9710919B (en) 1999-06-04
ID23373A (id) 2000-04-20
FR2756736A1 (fr) 1998-06-12
DZ2362A1 (fr) 2002-12-28
CA2273990A1 (fr) 1998-06-11
CN1239887A (zh) 1999-12-29
IL129936A0 (en) 2000-02-29
JP2000507618A (ja) 2000-06-20
HUP0001386A3 (en) 2002-03-28
MY132819A (en) 2007-10-31
IS5062A (is) 1999-06-01
AU716575B2 (en) 2000-03-02
NZ335750A (en) 2001-06-29
KR20000069308A (ko) 2000-11-25

Similar Documents

Publication Publication Date Title
AR009651A1 (es) Composicion solubilizante/estabilizante anhidra, emulsionable o microemulsionable en agua, para la solubilizacion de los derivados hidrofobosde n-sulfonil indolina, composicion farmaceutica microemulsionable o emulsionable en medio acuoso, y capsulas farmaceuticas, particularmente blandas
FR2405711A1 (fr) Composition pharmaceutique contenant de l'amoxycilline et du clavulanate de potassium
CO5560559A2 (es) Formulacion de suspension oral estabilizada
DK0587744T3 (da) Tygbar sammensætning til frigørelse af et lægemiddel
CO5560558A2 (es) Uso de una composicion de celecoxib para rapido alivio del dolor
ATE429210T1 (de) Orale flüssige zusammensetzungen
PT94485A (pt) Metodo para a preparacao de uma formulacao gel topica estavel, cosmeticamente aceitavel, contendo uma tetraciclina, util no tratamento do acne
BRPI0015567B8 (pt) composto, composição farmacêutica, forma de unidade de dosagem, uso da composição farmacêutica e método para preparar uma composição farmacêutica
CY1109567T1 (el) Φαρμακευτικες συνθεσεις που περιεχουν δροσπιρενονη
ES2187467T3 (es) Composiciones liquidas de proteccion solar con buena deposicion y formacion de espuma.
ES2110377T1 (es) Formulacion galenica de fenofibrato y aplicacion de la misma.
ES2184310T3 (es) Formulacion autoemulsionante para compuestos lipofilos acidos.
CY1106542T1 (el) Μεθοδος για παρασκευη φαρμακευτικων συνθεσεων για χρηση με συνταγοποιησεις μαλακης ζελατινης
BRPI0611170A2 (pt) composições injetáveis e processo para o preparo de tais composições
DE60011771D1 (de) Formulierung enthaltend testosteonundecanoat und rizinusöl
PE20021017A1 (es) Composicion parenteral reconstituible
AR040527A1 (es) Formulaciones de hgh en alta concentracion que contienen glicina
CA2175494A1 (en) Microparticular Pharmaceutical Compositions
ES2224917T1 (es) Composiciones farmaceuticas de agente fibrinolitico.
AR030064A1 (es) Metodos para inhibir los efectos uterotroficos de los agentes estrogenicos
GB2391471B (en) Pharmaceutical compositions
JP2006312628A (ja) アシタザノラスト含有水性組成物
HUP0002683A2 (hu) Terápiás anyagok sejtekhez való eljuttatásának fokozására szolgáló készítmények és módszerek
CA1249223A (en) Solid drug formulations and stable suspensions
RU99114019A (ru) Фармацевтические композиции, содержащие производные n-сульфонилиндолина